4//SEC Filing
Baumal Caroline 4
Accession 0001127602-24-001432
CIK 0001492422other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:33 PM ET
Size
7.0 KB
Accession
0001127602-24-001432
Insider Transaction Report
Form 4
Baumal Caroline
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-16$66.30/sh+37,000$2,453,100→ 37,000 totalExercise: $66.30Exp: 2034-01-15→ Common Stock (37,000 underlying) - Award
Common Stock
2024-01-16+25,445→ 58,376.37 total
Footnotes (2)
- [F1]This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
- [F2]This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001961100
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:33 PM ET
- Size
- 7.0 KB